CCL2 (monocyte chemoattractant protein-1) and cancer
- 1 June 2004
- journal article
- review article
- Published by Elsevier in Seminars in Cancer Biology
- Vol. 14 (3) , 149-154
- https://doi.org/10.1016/j.semcancer.2003.10.009
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Inflammation in atherosclerosisNature, 2002
- Elevated Circulating Levels of Monocyte Chemoattractant Protein-1 in Patients With Restenosis After Coronary AngioplastyArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1Nature, 2000
- A Novel Polymorphism in the MCP-1 Gene Regulatory Region That Influences MCP-1 ExpressionBiochemical and Biophysical Research Communications, 1999
- Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice.Journal of Clinical Investigation, 1997
- The origin and function of tumor-associated macrophagesImmunology Today, 1992
- Macrophage infiltration and growth of sarcoma clones expressing different amounts of monocyte chemotactic protein/JEInternational Journal of Cancer, 1991
- Properties of monocyte chemotactic and activating factor (MCAF) purified from a human fibrosarcoma cell line.The Journal of Experimental Medicine, 1990
- A high macrophage content in human breast cancer is not associated with favourable prognostic factorsBritish Journal of Surgery, 1984
- Experimentelle Studien an MäusetumorenZeitschrift für Krebsforschung und Klinische Onkologie, 1907